index
MSCI World Equal Weighted
Equal-weighted developed-market equities
Index Battle · Evidence-first comparison
MSCI World Equal Weighted vs Nasdaq-100: Which Exposure Fits Your Portfolio?
The most evenly spread developed-market index in this set, against one of the most concentrated.
Last reviewed: 26 August 2026IndependentNo paid placementsInformational only
vs
index
Nasdaq-100
Large non-financial Nasdaq-listed companies
Overall verdict
MSCI World Equal Weighted takes the developed-market universe and assigns every constituent the same weight at each rebalance, which pushes exposure decisively toward smaller and non-US companies relative to a cap-weighted index. The Nasdaq-100 does the opposite: a hundred large companies, selected by listing venue with financials excluded, and weighted so the largest still dominate. These are the two extremes of construction.
Quick Decision
Choose MSCI World Equal Weighted if…
you want the outcome driven by the average developed-market company rather than by the largest, and accept the higher turnover an equal-weight rebalance implies.
Choose Nasdaq-100 if…
you want concentrated exposure to the large Nasdaq-listed cohort and are sizing it as a satellite position.
Either can make sense if…
the two are not mixed casually — their concentration profiles pull in opposite directions and the blend needs an explicit target weight.
At a glance
Entity characteristics—not reference-product fees.
| Characteristic | MSCI World Equal Weighted | Nasdaq-100 |
|---|---|---|
| Exposure | Equal-weighted developed-market equities | Large non-financial Nasdaq-listed companies |
| Geography | Developed markets worldwide | United States |
| Market coverage | Large and mid cap | Large cap |
| Emerging markets | Not included | Not included |
| Small caps | Not included | Not included |
| Weighting | Equal weighted | Modified market-cap weighted |
| Index provider | MSCI | Nasdaq |
Five key differences
- 1.Exposure: Equal-weighted developed-market equities compared with Large non-financial Nasdaq-listed companies.
- 2.Geography: Developed markets worldwide compared with United States.
- 3.Market coverage: Large and mid cap compared with Large cap.
- 4.Weighting: Equal weighted compared with Modified market-cap weighted.
- 5.Index provider: MSCI compared with Nasdaq.
Decision scorecard
ExposureDepends
GeographyDepends
Market coverageDepends
WeightingDepends
Index providerDepends
“Depends” means the category reflects an investor objective, not universal superiority.
Coverage, countries and sectors
Verified holdings, concentration, country and sector datasets are not currently connected. When available, each dataset will be labelled as official index data or Reference ETF holdings; listing domicile will not be presented as economic revenue exposure.
What this means in a portfolio
The Nasdaq-100's constituents also appear in the equal-weighted developed index, but at a tiny fraction of their cap-weighted importance. Combining the two effectively restores part of the mega-cap tilt the equal-weight index was chosen to remove.
Common mistake
Assuming equal weighting is a low-risk choice. It systematically increases exposure to smaller constituents and to the rebalancing discipline itself, which behaves differently in trending markets.
Historical comparison basis
Historical performance is represented using Grovcap-selected reference exchange-traded products. It is not the official index or spot return series. Fund or ETP returns can differ because of fees, taxes, tracking, cash positions, product structure and other implementation effects. Differences can reflect TER, tracking difference, withholding taxes, sampling, securities lending, cash drag, operating expenses, currency conversion and inception date.
No period is currently comparable across both reference products on a like-for-like currency, basis and reporting-date footing, so no return figures are shown. Grovcap never renders a missing return as 0.00%.
Grovcap does not currently hold a daily net-asset-value time series for these products. Indexed performance charts, annualised volatility, maximum drawdown and return-per-risk therefore remain unavailable rather than being estimated from period returns.
Reference instruments used
One canonical European exchange-traded product per exposure, chosen by published rules: exact benchmark family, active and published, plain long-only, then accumulating, unhedged, longest usable history and largest established product.
MSCI World Equal Weighted reference product
Invesco MSCI World Equal Weight UCITS ETF Acc | Invesco UK
- ISIN
- IE000OEF25S1
- Product type
- UCITS ETF
- Provider
- Invesco
- Tracked benchmark
- MSCI World Equal Weighted Net Total Return USD Index
- Distribution
- Accumulating
- Currency hedging
- Not currently available
- Replication
- Physical
- Domicile
- Ireland
- Base currency
- USD
- Ongoing charge (TER)
- 0.20%
- Fund size
- $1.78bn
- Inception
- 5 Sept 2024
Selected deterministically from 1 eligible product in the Grovcap database — never by commercial arrangement.
Nasdaq-100 reference product
iShares NASDAQ 100 UCITS ETF
- ISIN
- IE00B53SZB19
- Product type
- UCITS ETF
- Provider
- Ishares
- Tracked benchmark
- NASDAQ 100 Index
- Distribution
- Accumulating
- Currency hedging
- Unhedged
- Replication
- Replicated
- Domicile
- Ireland
- Base currency
- USD
- Ongoing charge (TER)
- 0.30%
- Fund size
- $26.89bn
- Inception
- 26 Jan 2010
Selected deterministically from 15 eligible products in the Grovcap database — never by commercial arrangement.
Continue researching
Related Grovcap guides, rankings and tools to take the next step.
Best ETFsBest MSCI World UCITS ETFsEvery plain MSCI World UCITS share class compared on cost, size and structure.Best ETFsBest Nasdaq-100 UCITS ETFsA distinct, concentrated US equity exposure compared on cost and structure.PortfolioIs One All-World ETF Enough?Separate genuine diversification from overlap and intentional tilts.ToolsETF Comparison ToolPut any UCITS ETFs side by side on the fields that drive your decision.EducationETF MasterclassStructured lessons covering ETF mechanics, costs and investor behaviour.
Disclaimer
The information provided by Grovcap is for informational and educational purposes only and does not constitute investment, financial, legal, or tax advice. Investing involves risk, including the possible loss of capital. Always conduct your own research or consult a qualified professional before making investment decisions.
Your responses to quizzes, surveys, and other interactive features may be used in aggregated and anonymized form to improve Grovcap and generate investor insights. We do not sell personally identifiable information to third parties. For more information about how we collect, use, and protect your data, please refer to our Privacy Policy.